Skip to content

LIEPHAR: what changed

BE 0862.571.213NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€73,219
2024 · €137,746-€64,527
Equity
€846,006
2024 · €822,787+€23,219
Cash
€182,497
2024 · €169,013+€13,484
Balance sheet total
€1.6m
2024 · €1.6m-€46,547

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€41,209

    down €41,209 (-4.9%), from €845,305 to €804,096

    of which Other tangible fixed assets: -€40,742

Equity and liabilities
  • Debts after one year -€43,701

    down €43,701 (-7.7%), from €567,643 to €523,942

  • Short-term financial debts -€40,000

    down €40,000 (-54.5%), from €73,333 to €33,333

  • Profit (loss) carried forward +€23,219

    up €23,219 (+3.6%), from €639,037 to €662,256

Income statement
  • Depreciation +€47,349

    up €47,349 (+253%), from €18,701 to €66,050

  • Write-downs +€37,976

    new in 2025: €37,976

  • Gross operating margin +€20,621

    up €20,621 (+6.6%), from €311,845 to €332,467

  • Taxes -€3,416

    down €3,416 (-30.0%), from €11,399 to €7,983

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €137,746
Gross operating margin +€20,621
Staff costs -€1,500
Depreciation -€47,349
Write-downs -€37,976
Other operating charges +€3
Financial income -€946
Financial charges -€795
Taxes +€3,416
Result 2025 €73,219
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€170,660
Investment -€24,841
Financing -€132,335
Cash 2024 €169,013
Net result for the year +€73,219
Depreciation +€66,050
Stocks and contracts +€5,769
Receivables within one year +€14,398
Deferred charges and accrued income -€1,344
Trade debts +€6,772
Tax, wage and social debts +€5,884
Accrued charges and deferred income -€87
Investment in fixed assets (net) -€24,841
Debts after one year -€43,701
Current portion of long-term debt +€1,366
Short-term financial debts -€40,000
Contributions, distributions and other -€50,000
Cash 2025 €182,497
brings cash intakes cash out
Every line side by side 52 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,635,053 €1,588,507 -€46,547 -2.8%
Fixed assets 21/28 €845,305 €804,096 -€41,209 -4.9%
Tangible fixed assets 22/27 €845,305 €804,096 -€41,209 -4.9%
Land and buildings 22 €130,585 €126,352 -€4,233 -3.2%
Plant, machinery and equipment 23 €13,829 €15,187 +€1,359 +9.8%
Furniture and vehicles 24 €13,629 €16,036 +€2,407 +17.7%
Other tangible fixed assets 26 €687,263 €646,521 -€40,742 -5.9%
Current assets 29/58 €789,748 €784,411 -€5,338 -0.7%
Stocks and contracts in progress 3 €230,279 €224,510 -€5,769 -2.5%
Stocks 30/36 €230,279 €224,510 -€5,769 -2.5%
Amounts receivable within one year 40/41 €382,999 €368,601 -€14,398 -3.8%
Trade receivables 40 €111,123 €100,989 -€10,134 -9.1%
Other amounts receivable 41 €271,875 €267,612 -€4,263 -1.6%
Cash at bank and in hand 54/58 €169,013 €182,497 +€13,484 +8.0%
Deferred charges and accrued income 490/1 €7,458 €8,803 +€1,344 +18.0%
Total equity and liabilities 10/49 €1,635,053 €1,588,507 -€46,547 -2.8%
Equity 10/15 €822,787 €846,006 +€23,219 +2.8%
Contributions 10/11 €150,000 €150,000 = 0.0%
Capital 10 €150,000 €150,000 = 0.0%
Issued capital 100 €150,000 €150,000 = 0.0%
Reserves 13 €33,750 €33,750 = 0.0%
Non-distributable reserves 130/1 €15,000 €15,000 = 0.0%
Legal reserve 130 €15,000 €15,000 = 0.0%
Tax-exempt reserves 132 €18,750 €18,750 = 0.0%
Profit (loss) carried forward 14 €639,037 €662,256 +€23,219 +3.6%
Amounts payable 17/49 €812,267 €742,501 -€69,766 -8.6%
Amounts payable after more than one year 17 €567,643 €523,942 -€43,701 -7.7%
Financial debts 170/4 €567,643 €523,942 -€43,701 -7.7%
Amounts payable within one year 42/48 €243,181 €217,204 -€25,977 -10.7%
Current portion of amounts payable after more than one year 42 €45,919 €47,285 +€1,366 +3.0%
Financial debts 43 €73,333 €33,333 -€40,000 -54.5%
Credit institutions 430/8 €73,333 €33,333 -€40,000 -54.5%
Trade debts 44 €69,308 €76,081 +€6,772 +9.8%
Suppliers 440/4 €69,308 €76,081 +€6,772 +9.8%
Taxes, remuneration and social security 45 €4,620 €10,505 +€5,884 +127%
Remuneration and social security 454/9 €4,620 €10,505 +€5,884 +127%
Other amounts payable 47/48 €50,000 €50,000 = 0.0%
Accrued charges and deferred income 492/3 €1,443 €1,356 -€87 -6.1%
Remuneration, social security and pensions 62 €127,103 €128,604 +€1,500 +1.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €18,701 €66,050 +€47,349 +253%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €37,976 +€37,976
Other operating charges 640/8 €3 - -€3
Gross operating margin 9900 €311,845 €332,467 +€20,621 +6.6%
Operating profit (loss) 9901 €166,038 €99,837 -€66,202 -39.9%
Financial income 75/76B €2,669 €1,722 -€946 -35.5%
Recurring financial income 75 €2,669 €1,722 -€946 -35.5%
Financial charges 65/66B €19,562 €20,358 +€795 +4.1%
Recurring financial charges 65 €19,562 €20,358 +€795 +4.1%
Profit (loss) for the period before taxes 9903 €149,145 €81,201 -€67,943 -45.6%
Income taxes 67/77 €11,399 €7,983 -€3,416 -30.0%
Profit (loss) for the period 9904 €137,746 €73,219 -€64,527 -46.8%
Profit (loss) for the period to be appropriated 9905 €137,746 €73,219 -€64,527 -46.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€801,803 to €953,323

Midpoint €864,936 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €846,006
Capitalised earnings €757,600 to €1.1m
Indication €801,803 to €953,323

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€846,006
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€846,006

Capitalised earnings

net result for the year (9904)
2025
€73,219
2024
€137,746
2023
€107,228
2022
€106,140
excluding non-recurring income and charges
€108,104
2021
€125,124
Average result
€106,064
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€757,600 / €883,867 / €1.1m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.